Publiserte artikler 2010

1. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol 2010; 39(3):675-694.
2. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42(5):441-447.
3. Manual for coding and reporting haematological malignancies. Tumori 2010; 96(4):i-A32.
4. Agostini M, Ferro G, Olsson A, Burstyn I, De VF, Hansen J, Lassen CF, Johansen C, Kjaerheim K, Langard S, Stucker I, Ahrens W, Behrens T, Lindbohm ML, Heikkila P, Heederik D, Portengen L, Shaham J, Boffetta P, Kromhout H. Exposure Assessment for a Nested Case-Control Study of Lung Cancer among European Asphalt Workers. Ann Occup Hyg 2010; 18(10):1418-24.
5. Andersson K, Bray F, Arbyn M, Storm H, Zanetti R, Hallmans G, Coebergh JW, Dillner J. The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives. Acta Oncol 2010; 49(8):1227-1234.
   http://www.ncbi.nlm.nih.gov/pubmed/20583946?dopt=Citation
6. Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arslan A, Othieno E, Binta-Kahwa J, van Doorn LJ, Kleter B, Quint W, Weiderpass E. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer 2010; 102(2):262-267.
   http://www.ncbi.nlm.nih.gov/pubmed/19997105?dopt=Citation
7. Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E. Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda. Infect Agent Cancer 2010; 5(1):7.
   http://www.ncbi.nlm.nih.gov/pubmed/20380709?dopt=Citation
8. Berrington de GA, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363(23):2211-2219.
9. Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic Syndrome and Endometrial Carcinoma. Am J Epidemiol 2010; 171(8):892-902.
   http://www.ncbi.nlm.nih.gov/pubmed/20219764?dopt=Citation
10. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Haggstrom C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19(7):1737-1745.
11. Brackmann S, Aamodt G, Andersen SN, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer. Inflamm Bowel Dis 2010; 16(3):474-481.
    http://www.ncbi.nlm.nih.gov/pubmed/19714748?dopt=Citation
12. Bray F.I., Weiderpass E. Lung cancer mortality trends in 36 European countries: Secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer 2010; 126(6):1454-1466.
    http://www.ncbi.nlm.nih.gov/pubmed/19728330?dopt=Citation
13. Bray F, Engholm G, Hakulinen T, Gislum M, Tryggvadottir L, Storm HH, Klint A. Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 2010; 49(5):673-693.
    http://www.ncbi.nlm.nih.gov/pubmed/20192877?dopt=Citation
14. Bray F, Klint A, Gislum M, Hakulinen T, Engholm G, Tryggvadottir L, Storm HH. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 2010; 49(5):644-654.
    http://www.ncbi.nlm.nih.gov/pubmed/20151937?dopt=Citation
15. Bretthauer M. Evidence for colorectal cancer screening. Best Pract Res Clin Gastroenterol 2010; 24(4):417-425.
16. Bugge MD, Kjuus H, Martinsen JI, Kjaerheim K. Cancer incidence among short- and long-term workers in the Norwegian silicon carbide industry. Scand J Work Environ Health 2010; 36(1):71-79.
    http://www.ncbi.nlm.nih.gov/pubmed/19953212?dopt=Citation
17. Chuang SC, Scelo G, Lee YC, Friis S, Pukkala E, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Tamaro S, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Boffetta P, Brennan P, Hashibe M. Risks of second primary cancer among patients with major histological types of lung cancers in both men and women. Br J Cancer 2010; 102(7):1190-1195.
    http://www.ncbi.nlm.nih.gov/pubmed/20354532?dopt=Citation
18. Conway DI, McKinney PA, McMahon AD, Ahrens W, Schmeisser N, Benhamou S, Bouchardy C, Macfarlane GJ, Macfarlane TV, Lagiou P, Minaki P, Bencko V, Holcatova I, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Talamini R, Barzan L, Canova C, Simonato L, Lowry RJ, Znaor A, Healy CM, McCartan BE, Marron M, Hashibe M, Brennan P. Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer 2010; 46(3):588-598.
    http://www.ncbi.nlm.nih.gov/pubmed/19857956?dopt=Citation
19. Coupland VH, Okello C, Davies EA, Bray F, Moller H. The future burden of cancer in London compared with England. J Public Health (Oxf) 2010; 32(1):83-90.
    http://www.ncbi.nlm.nih.gov/pubmed/19679689?dopt=Citation
20. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 2010; 102(11):1665-9.
    http://www.ncbi.nlm.nih.gov/pubmed/20407437?dopt=Citation
21. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R. Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 2010; 17(3):139-146.
22. Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 2010; 121(3):651-60.
    http://www.ncbi.nlm.nih.gov/pubmed/19882245?dopt=Citation
23. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Kotlum JE, Olafsdottir E, Pukkala E, Storm HH. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49(5):725-736.
    http://www.ncbi.nlm.nih.gov/pubmed/20491528?dopt=Citation
24. Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010; 49(5):545-560.
25. Engholm G, Hakulinen T, Gislum M, Tryggvadottir L, Klint A, Bray F, Storm HH. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):655-664.
    http://www.ncbi.nlm.nih.gov/pubmed/20156116?dopt=Citation
26. Gatta G, Capocaccia R, Trama A, Martinez-Garcia C. The burden of rare cancers in Europe. Adv Exp Med Biol 2010; 686:285-303.
27. Glavin K, Smith L, Sorum R, Ellefsen B. Redesigned community postpartum care to prevent and treat postpartum depression in women--a one-year follow-up study. J Clin Nurs 2010; 19(21-22):3051-3062.
28. Glavin K, Smith L, Sorum R, Ellefsen B. Supportive counselling by public health nurses for women with postpartum depression. J Adv Nurs 2010; 66(6):1317-27.
    http://www.ncbi.nlm.nih.gov/pubmed/20384641?dopt=Citation
29. Grimsrud TK, Andersen A. Evidence of carcinogenicity in humans of water-soluble nickel salts. J Occup Med Toxicol 2010; 5(1):7.
    http://www.ncbi.nlm.nih.gov/pubmed/20377901?dopt=Citation
30. Hakulinen T, Engholm G, Gislum M, Storm HH, Klint A, Tryggvadottir L, Bray F. Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):608-23.
    http://www.ncbi.nlm.nih.gov/pubmed/20170292?dopt=Citation
31. Hakulinen T, Tryggvadottir L, Gislum M, Storm HH, Bray F, Klint A, Engholm G. Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):561-77.
    http://www.ncbi.nlm.nih.gov/pubmed/20170293?dopt=Citation
32. Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, Lied B, Ronning P, Skaar S, Spetalen S, Helseth E. Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery 2010; 67(6):1622-1631.
33. Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Morkrid L, Ueland PM. Analytical Recovery of Folate and Its Degradation Products in Human Serum Stored at -25{degrees}C for up to 29 Years. J Nutr 2010; 140(3):522-526.
    http://www.ncbi.nlm.nih.gov/pubmed/20071651?dopt=Citation
34. Hansen BT, Kjaer SK, Munk C, Tryggvadottir L, Sparen P, Hagerup-Jenssen M, Liaw KL, Nygard M. Early smoking initiation, sexual behavior and reproductive health - a large population based study of Nordic women. Prev Med 2010; 51(1):68-72.
    http://www.ncbi.nlm.nih.gov/pubmed/20353801?dopt=Citation
35. Hansen BT, Hagerup-Jenssen M, Kjaer SK, Munk C, Tryggvadottir L, Sparen P, Liaw KL, Nygard M. Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect 2010; 86(4):258-262.
36. Hedelin M, Lof M, Olsson M, Lewander T, Nilsson B, Hultman CM, Weiderpass E. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population. BMC Psychiatry 2010; 10:38.
37. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 2010; 122(3):159-167.
38. Hemminki K, Tretli S, Olsen JH, Tryggvadottir L, Pukkala E, Sundquist J, Granstrom C. Familial risks in nervous system tumours: joint Nordic study. Br J Cancer 2010; 102(12):1786-1790.
39. Hernes E, Kyrdalen A, Kvale R, Hem E, Klepp O, Axcrona K, Fossa SD. Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry. BJU Int 2010; 105(6):805-811.
    http://www.ncbi.nlm.nih.gov/pubmed/19735258?dopt=Citation
40. Hjartaker A, Meo MS, Weiderpass E. Alcohol and gynecological cancers: an overview. Eur J Cancer Prev 2010; 19(1):1-10.
    http://www.ncbi.nlm.nih.gov/pubmed/19926999?dopt=Citation
41. Hjartaker A, Thoresen M, Engeset D, Lund E. Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: the Norwegian Women and Cancer study. Cancer Causes Control 2010; 21(11):1875-1885.
42. Hoff G. Colorectal cancer screening in an expanding panorama of screening programmes. Best Pract Res Clin Gastroenterol 2010; 24(4):521-527.
43. Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Klint A, Peake M, Strand TE, Linklater K, Robinson D, Moller H. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010; 65(5):436-441.
44. Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, Coebergh JW. Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers. J Clin Oncol 2010; 28(15):2520-9.
    http://www.ncbi.nlm.nih.gov/pubmed/20406936?dopt=Citation
45. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjorge T, Concin H, Almquist M, Haggstrom C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 2010; 19(9):2307-2317.
46. Jonsson V, Tjonnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M. Familial chronic lymphocytic leukemia in norway and denmark. Comments on pleiotropy and birth order. In Vivo 2010; 24(1):85-95.
    http://www.ncbi.nlm.nih.gov/pubmed/20133982?dopt=Citation
47. Juel IM, Skaane P, Hoff SR, Johannessen G, Hofvind S. Screen-film mammography versus full-field digital mammography in a population-based screening program: The Sogn and Fjordane study. Acta Radiol 2010; 51(9):962-968.
48. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363(13):1203-1210.
49. Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11(6):530-542.
50. Kheifets L, Ahlbom A, Crespi CM, Feychting M, Johansen C, Monroe J, Murphy MF, Oksuzyan S, Preston-Martin S, Roman E, Saito T, Savitz D, Schuz J, Simpson J, Swanson J, Tynes T, Verkasalo P, Mezei G. A pooled analysis of extremely low-frequency magnetic fields and childhood brain tumors. Am J Epidemiol 2010; 172(7):752-761.
51. Kjaerheim K, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Effects of occupation on risks of avoidable cancers in the Nordic countries. Eur J Cancer 2010; 46(14):2545-2554.
52. Klint A, Tryggvadottir L, Bray F, Gislum M, Hakulinen T, Storm HH, Engholm G. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):632-643.
53. Klint A, Engholm G, Storm HH, Tryggvadottir L, Gislum M, Hakulinen T, Bray F. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):578-607.
54. Kvale R, Moller B, Angelsen A, Dahl O, Fossa SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F. Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. Cancer Epidemiol 2010; 34(4):359-367.
55. Kvarme LG, Helseth S, Sorum R, Luth-Hansen V, Haugland S, Natvig GK. The effect of a solution-focused approach to improve self-efficacy in socially withdrawn school children: A non-randomized controlled trial. Int J Nurs Stud 2010; 47(11):1389-1396.
56. Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fossa SD. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis 2010; 13(2):144-150.
    http://www.ncbi.nlm.nih.gov/pubmed/20101260?dopt=Citation
57. Laake I, Thune I, Selmer R, Tretli S, Slattery ML, Veierod MB. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev 2010; 19(6):1511-1522.
58. Langseth H, Luostarinen T, Bray F, Dillner J. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 2010; 49(3):368-377.
    http://www.ncbi.nlm.nih.gov/pubmed/20059313?dopt=Citation
59. Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: An interpretation of the temporal patterns by anatomic subsite. Int J Cancer 2010; 126(3):721-732.
    http://www.ncbi.nlm.nih.gov/pubmed/19688825?dopt=Citation
60. Lepage C, Ciccolallo L, De AR, Bouvier AM, Faivre J, Gatta G. European disparities in malignant digestive endocrine tumours survival. Int J Cancer 2010; 126(12):2928-2934.
61. Lindemann K, Eskild A, Vatten LJ, Bray F. Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027. Int J Cancer 2010; 127(11):2661-2668.
62. Lips EH, Gaborieau V, McKay JD, Chabrier A, Hung RJ, Boffetta P, Hashibe M, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Field JK, Liloglou T, Xinarianos G, McLaughlin J, Liu G, Skorpen F, Elvestad MB, Hveem K, Vatten L, Study E, Benhamou S, Lagiou P, Holcatova I, Merletti F, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Barzan L, Canova C, Lowry R, Conway DI, Znaor A, Healy C, Curado MP, Koifman S, Eluf-Neto J, Matos E, Menezes A, Fernandez L, Metspalu A, Heath S, Lathrop M, Brennan P. Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. Int J Epidemiol 2010; 39(2):563-567.
    http://www.ncbi.nlm.nih.gov/pubmed/19776245?dopt=Citation
63. Macfarlane TV, Macfarlane GJ, Oliver RJ, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Lagiou A, Castellsague X, Agudo A, Merletti F, Richiardi L, Kjaerheim K, Slamova A, Schejbalova M, Canova C, Simonato L, Talamini R, Barzan L, Conway DI, McKinney PA, Znaor A, Lowry RJ, Thomson P, Healy CM, McCartan BE, Marron M, Hashibe M, Brennan P. The aetiology of upper aerodigestive tract cancers among young adults in Europe: the ARCAGE study. Cancer Causes Control 2010; 21(12):2213-2221.
64. Maehle BO, Vatten LJ, Tretli S. Birth length and weight as predictors of breast cancer prognosis. BMC Cancer 2010; 10(1):115.
    http://www.ncbi.nlm.nih.gov/pubmed/20346122?dopt=Citation
65. Meyer MS, Mucci LA, Andersson SO, Andren O, Johansson JE, Tretli S, Adami HO. Homogeneous Prostate Cancer Mortality in the Nordic Countries Over Four Decades. Eur Urol 2010; 58(3):427-32.
66. Moller H, Sandin F, Bray F, Klint A, Linklater KM, Purushotham A, Robinson D, Holmberg L. Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 2010; 127(11):2630-2638.
67. Mork J, Moller B, Dahl T, Bray F. Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 2010; 21(9):1397-1405.
68. Mutyaba T, Mirembe F, Sandin S, Weiderpass E. Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda. Reprod Health 2010; 7(1):4.
69. Odida M, Lloveras B, Guimera N, Weiderpass E. The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix. BMC Res Notes 2010; 3(1):54.
    http://www.ncbi.nlm.nih.gov/pubmed/20199664?dopt=Citation
70. Odida M, de SS, Sandin S, Quiros B, Alemany L, Lloveras B, Quint W, Kleter B, Alejo M, van Doorn LJ, Weiderpass E. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer 2010; 5:15.
71. Olsson A, Kromhout H, Agostini M, Hansen J, Lassen CF, Johansen C, Kjaerheim K, Langard S, Stucker I, Ahrens W, Behrens T, Lindbohm ML, Heikkila P, Heederik D, Portengen L, Shaham J, Ferro G, De VF, Burstyn I, Boffetta P. A case-control study of lung cancer nested in a cohort of European asphalt workers. Environ Health Perspect 2010; 118(10):1418-1424.
72. Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 2010; 290(1-2):66-9.
73. Robsahm TE, Hestvik UE, Veierod MB, Fagerlie A, Nystad W, Engebretsen L, Tretli S. Cancer risk in Norwegian world class athletes. Cancer Causes Control 2010; 21(10):1711-9.
74. Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: The role of screening and a comparison with data from the United States. Eur J Cancer 2010; 46(18):3351-7.
75. Sandeck HP, Roe OD, Kjaerheim K, Willen H, Larsson E. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry. Diagn Pathol 2010; 5(1):47.
76. Sant M, Allemani C, Tereanu C, De AR, Capocaccia R, Visser O, Marcos-Gragera R, Maynadie M, Simonetti A, Lutz JM, Berrino F. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116(19):3724-3734.
77. Schmeisser N, Conway DI, McKinney PA, McMahon AD, Pohlabeln H, Marron M, Benhamou S, Bouchardy C, Macfarlane GJ, Macfarlane TV, Lagiou P, Lagiou A, Bencko V, Holcatova I, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Talamini R, Polesel J, Canova C, Simonato L, Lowry R, Znaor A, Healy C, McCarten BE, Hashibe M, Brennan P, Ahrens W. Life course social mobility and risk of upper aerodigestive tract cancer in men. Eur J Epidemiol 2010; 25(3):173-82.
78. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygard M, Karki BS, Snijders PJ, Meijer CJ, Franceschi S. Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 2010; 21(3):323-330.
    http://www.ncbi.nlm.nih.gov/pubmed/20199664?dopt=Citation
79. Skeie G, Hjartaker A, Braaten T, Lund E. Dietary change among breast and colorectal cancer survivors and cancer-free women in the Norwegian Women and Cancer cohort study. Cancer Causes Control 2010; 20(10):1955-66.
    http://www.ncbi.nlm.nih.gov/pubmed/19565341?dopt=Citation
80. Soreide K, Aagnes B, Moller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol 2010; 45(1):82-92.
    http://www.ncbi.nlm.nih.gov/pubmed/19883280?dopt=Citation
81. Sorum R, Hofvind S, Skaane P, Haldorsen T. Trends in incidence of ductal carcinoma in situ: The effect of a population-based screening programme. Breast 2010; 19(6):499-505.
82. Storm HH, Klint A, Tryggvadottir L, Gislum M, Engholm G, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):694-712.
83. Storm HH, Kejs AM, Engholm G, Tryggvadottir L, Klint A, Bray F, Hakulinen T. Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix. Acta Oncol 2010; 49(5):713-724.
84. Storm HH, Engholm G, Hakulinen T, Tryggvadottir L, Klint A, Gislum M, Kejs AM, Bray F. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 2010; 49(5):532-544.
85. Strand LA, Martinsen JI, Koefoed VF, Sommerfelt-Pettersen J, Grimsrud TK. Asbestos-related cancers among 28,300 military servicemen in the Royal Norwegian Navy. Am J Ind Med 2010; 53(1):64-71.
    http://www.ncbi.nlm.nih.gov/pubmed/19921706?dopt=Citation
86. Strand TE, Rostad H, Wentzel-Larsen T, von PC. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J 2010; 36(2):401-407.
87. Syse A, Loge JH, Lyngstad TH. Does Childhood Cancer Affect Parental Divorce Rates? A Population-Based Study. J Clin Oncol 2010; 28(5):872-877.
    http://www.ncbi.nlm.nih.gov/pubmed/20038725?dopt=Citation
88. Tornberg S, Kemetli L, Ascunce N, Hofvind S, Anttila A, Seradour B, Paci E, Guldenfels C, Azavedo E, Frigerio A, Rodrigues V, Ponti A. A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev 2010; 19(2):87-93.
89. Tryggvadottir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, Engholm G. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):624-631.
90. Tryggvadottir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, Bray F. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49(5):665-672.
91. Veierod MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev 2010; 19(1):111-120.
    http://www.ncbi.nlm.nih.gov/pubmed/20056629?dopt=Citation
92. Veierod MB, Smedby KE, Lund E, Adami HO, Weiderpass E. Pigmentary characteristics, UV radiation exposure, and risk of non-Hodgkin lymphoma: a prospective study among Scandinavian women. Cancer Epidemiol Biomarkers Prev 2010; 19(6):1569-1576.
93. Veierod MB, Nilsen LT, Robsahm TE. [Solaria, vitamin D, and skin cancer]. Tidsskr Nor Laegeforen 2010; 130(18):1818-1821.
94. Weedon-Fekjaer H, Tretli S, Aalen OO. Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening. Stat Methods Med Res 2010; 19(5):507-27.
    http://www.ncbi.nlm.nih.gov/pubmed/20356856?dopt=Citation
95. Weiderpass E. Lifestyle and cancer risk. J Prev Med Public Health 2010; 43(6):459-471.
96. Wethal T, Haugnes HS, Kjekshus J, Smastuen MC, Ueland T, Aukrust P, Fossa SD. C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? Eur J Cancer 2010; 46(18):3425-33.